Search | IOVS | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Enhanced Ocular Tissue Permeation of Brinzolamide Administered via OcuSurf LNP

Koushik Barman; Samuel Harris; Kevin Ward; Shikha P Barman

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1149.

ARVO Annual Meeting Abstract June 2023

Sphingolipid biosynthetic inhibitor, SPT-I, prevents oxidative-stress-mediated cell death in mouse photoreceptor-derived 661W cells

Faiza Tahia; Sandip Basu; Koushik Mondal; Harry Kochat; Kennard Brown; Nawajes Mandal

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1610.

ARVO Annual Meeting Abstract June 2022

Ocular Surface Sphingomyelinases, Meibum and Tear Sphingolipids, and Clinical Parameters of Meibomian Gland Dysfunction

Victor Sanchez; Anat Galor; Katherine Jensen; Koushik Mondal; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):426.

ARVO Annual Meeting Abstract June 2022

Retinal Characterization of Sphingosine-1-Phosphate Receptor 2 Knockout Mice

Richard Grambergs; Abhishek P. Shrestha; Koushik Mondal; TJ Hollingsworth; David M. Sherry; Thirumalani Vaithianathan; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1911 – A0057.

ARVO Annual Meeting Abstract June 2021

A Novel Topical Formulation of FTY720 Protects Photoreceptors in Animal Model of Light Induced Retinal Degeneration

Sandip K Basu; Jerome Cole II; Bano Qaladize; Koushik Mondal; Kaining Zhi; Babatunde Raji; Harry Kochat; Kennard Brown; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3076.

ARVO Annual Meeting Abstract June 2021

N-3 polyunsaturated fatty acids (n-3 PUFA) prevent traumatic brain injury (TBI)-mediated visual and motor deficits in mice by suppressing ceramide biosynthesis

Koushik Mondal; Haruka Takahashi; Jerome Cole II; Nobel Del Mar; Chunyan Li; Daniel Stephenson; Charles Chalfant; Jeremy Allegood; Lauren A Cowart; Anton Reiner; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3030.

Retina March 2021

Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants

PDF

Anand Vinekar; Archana Padmanabhan Nair; Shivani Sinha; Tanuja Vaidya; Koushik Chakrabarty; Rohit Shetty; Arkasubhra Ghosh; Swaminathan Sethu
TAGS: angiogenesis factor, biological markers, infant, premature, retinopathy of prematurity, screening, vascular endothelial growth factor a, infant, birth weight
Invest. Ophthalmol. Vis. Sci.. 2021; 62(3):2. https://doi.org/10.1167/iovs.62.3.2

Vision Sciences Society Annual Meeting Abstract October 2020

Image predictors of visual localization in natural scenes

Anna Kosovicheva; Koushik Sridhar; Peter J Bex

Journal of Vision. 2020; 20(11):183. https://doi.org/10.1167/jov.20.11.183

ARVO Annual Meeting Abstract June 2020

Sphingolipid Modulators as Retinitis Pigmentosa Therapeutics

Jerome Cole II; Sufiya Khanam; Koushik Mondal; Sandip K Basu; Kaining Zhi; Harry Kochat; Kennard Brown; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4284.

ARVO Annual Meeting Abstract June 2020

Modeling macular corneal dystrophy using corneal organoids from patient derived induced pluripotent stem cells

Koushik Chakrabarty; Karthikeyan Ramaswamy; Praveen Machiraju; Shubham Argulwar; Jagadeesh Naidu; Akshata Kulkarni; Rohit Shetty; Himanshu Matalia; Arkasubhra Ghosh

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4354.

ARVO Annual Meeting Abstract July 2019

Modulation of Sphingolipid metabolites in Type 2 Diabetic Retinopathy

Koushik Mondal; Todd Lydic; Rajashekhar Gangaraju; Julia V Busik; Nawajes A Mandal

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2681.

ARVO Annual Meeting Abstract July 2019

Efficient Delivery of a Hydrophobic PPAR Agonist OS300 via a Nanostructured Delivery System, for the Treatment of Meibomian Gland Dysfunction

Koushik Barman; Swathi Amere; Kevin Ward; Shikha P Barman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):282.

Vision Sciences Society Annual Meeting Abstract September 2018

Real-time Optimization for Visual Feature Identification

Jayanth Koushik; Austin Marcus; Aarti Singh; Michael Tarr

Journal of Vision. 2018; 18(10):413. https://doi.org/10.1167/18.10.413

ARVO Annual Meeting Abstract July 2018

Development of a Highly Bioavailable Nanocore-based (OcuSurf™) Ophthalmic Formulation for Treatment of Blepharitis

Kevin Ward; Koushik Barman; Chinghong Li; Shikha P Barman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):230.

ARVO Annual Meeting Abstract July 2018

A Highly Bioavailable Nanocore (OcuSurf™) Brinzolamide Drug Product for Glaucoma Therapy, Compared to Azopt™

Koushik Barman; Kevin Ward; Chinghong Li; Shikha P Barman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5690.

ARVO Annual Meeting Abstract June 2017

OcuSurf TM -Mediated Antimicrobial Therapies to Treat Multi-Drug Resistant Ocular Infections

Kevin L Ward; Shikha P Barman; Koushik Barman; Anne-Marie Cromwick; Kathryn S Crawford

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1084.

Vision Sciences Society Annual Meeting Abstract September 2015

Perceptual Training and Competition for Representation in Visual Cortex

Paige Scalf; Samantha Srivathsan Koushik; Autri Hafezi; Erica Wager; Jonathan Folstein

Journal of Vision. 2015; 15(12):1128. https://doi.org/10.1167/15.12.1128

ARVO Annual Meeting Abstract June 2015

Long Term Results of Prophylactic Laser For Fundal Coloboma

Ravi Bypareddy; Koushik Tripathy; Yog Raj Sharma; Rohan Chawla; Subodh Kumar singh; Pradeep Venkatesh; rajpal vohra; Babulal Kumawat; bushan wadekar

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5672.

ARVO Annual Meeting Abstract June 2015

Ultra-wide field fundus fluorescein angiography in rhegmatogenous retinal detachment

Bhushan Ratansingh Wadekar; Rohan Chawla; Koushik Tripathy; Raj Pal; Yog Raj Sharma; Harsh Inder Singh; Babulal Kumawat; Ravi Bypareddy; Pradeep Venkatesh; Vitreo-Retina Services, DR R P Centre, All India Institute of Medical Sciences

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):401.

ARVO Annual Meeting Abstract June 2015

A Novel, Non-invasive, S elf-Administered , Preservative-Free, Sustained Release Product (EySite-TP TM ) for Glaucoma Therapy

Shikha P Barman; Moli Liu; Kevin Ward; Koushik Barman; Kathryn Crawford; Thomas Leland; drug delivery

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4140.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Enhanced Ocular Tissue Permeation of Brinzolamide Administered via OcuSurf LNP

Sphingolipid biosynthetic inhibitor, SPT-I, prevents oxidative-stress-mediated cell death in mouse photoreceptor-derived 661W cells

Ocular Surface Sphingomyelinases, Meibum and Tear Sphingolipids, and Clinical Parameters of Meibomian Gland Dysfunction

Retinal Characterization of Sphingosine-1-Phosphate Receptor 2 Knockout Mice

A Novel Topical Formulation of FTY720 Protects Photoreceptors in Animal Model of Light Induced Retinal Degeneration

N-3 polyunsaturated fatty acids (n-3 PUFA) prevent traumatic brain injury (TBI)-mediated visual and motor deficits in mice by suppressing ceramide biosynthesis

Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants

Image predictors of visual localization in natural scenes

Sphingolipid Modulators as Retinitis Pigmentosa Therapeutics

Modeling macular corneal dystrophy using corneal organoids from patient derived induced pluripotent stem cells

Modulation of Sphingolipid metabolites in Type 2 Diabetic Retinopathy

Efficient Delivery of a Hydrophobic PPAR Agonist OS300 via a Nanostructured Delivery System, for the Treatment of Meibomian Gland Dysfunction

Real-time Optimization for Visual Feature Identification

Development of a Highly Bioavailable Nanocore-based (OcuSurf™) Ophthalmic Formulation for Treatment of Blepharitis

A Highly Bioavailable Nanocore (OcuSurf™) Brinzolamide Drug Product for Glaucoma Therapy, Compared to Azopt™

OcuSurf TM -Mediated Antimicrobial Therapies to Treat Multi-Drug Resistant Ocular Infections

Perceptual Training and Competition for Representation in Visual Cortex

Long Term Results of Prophylactic Laser For Fundal Coloboma

Ultra-wide field fundus fluorescein angiography in rhegmatogenous retinal detachment

A Novel, Non-invasive, S elf-Administered , Preservative-Free, Sustained Release Product (EySite-TP TM ) for Glaucoma Therapy

To View More...

You must be signed into an individual account to use this feature.